Brief: Landos Biopharma To Collaborate On A Phase 2 Study Of Omilancor In Crohn’S Disease With The Icahn School Of Medicine

Landos Biopharma

20/09/2021 12:46

Sept 20 (Reuters) - Landos Biopharma Inc  LABP.O :
    * LANDOS BIOPHARMA TO COLLABORATE ON A PHASE 2 STUDY OF
OMILANCOR
IN CROHN’S DISEASE WITH THE ICAHN SCHOOL OF MEDICINE AT MOUNT
SINAI
    * LANDOS BIOPHARMA INC - AWARDED A $3 MILLION NIH R01 GRANT
FROM
U.S. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
DISEASES TO FUND THIS STUDY
    * LANDOS BIOPHARMA INC - SECOND PHASE 2 TRIAL OF OMILANCOR
IN
CROHN'S DISEASE (CD), EXPECTED TO INITIATE IN 2021

Source text for Eikon:  ID:nGNX5JK1bz 
Further company coverage:  LABP.O 

 ((Reuters.Briefs@thomsonreuters.com;))